Industry 4.0

Industry Update

Editor's comment

'Interesting times' beckon for pharma and biotech

The scale of pharmaceutical counterfeiting can be staggering to behold – whether in terms of the number of cases, the financial incentives or the economic loss to the legitimate industry.

Analysis

Industry analysis: unleashing the potential of the IIoT

Technologies that connect us to the Internet of Things already exist, but don’t expect everyone to buy into the phenomenon just yet, writes Robert Smith.